Accessibility Menu
Nanosonics logo

Nanosonics(OTC) NNCSF

Market Cap$654.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)+128%
5 Year-45%
1 Year-14%
1 Month-14%
$2.19
+0.23%
+0.01Today
Nanosonics last closing stock price
MetricPriceDate
Last closeUSD 2.192026-07-23
Nanosonics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-14.12%USD 2.552026-06-22
1 month-14.12%USD 2.552026-06-22
3 month-21.79%USD 2.802026-04-13
Year to date-24.48%USD 2.902025-12-18
1 year-14.03%USD 2.552025-07-21
3 year-29.13%USD 3.092023-07-06
5 year-45.11%USD 3.992021-07-16
Since inception+128.13%USD 0.962010-11-05

Nanosonics Financials at a Glance

Market Cap

$654.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$390.31M

Net Income (TTM)

A$37.12M

EPS (TTM)

$0.04

P/E Ratio

50.23

Dividend

$0.00

Beta (Volatility)

0.16 (Low)

Price

$2.19

Volume

500

Open

$2.19

Previous Close

$2.19

Daily Range

$2.19 - $2.19

52-Week Range

$2.01 - $3.06

Estimated Earnings Date

Aug 24, 2026

NNCSF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Nanosonics

Nanosonics Limited is an innovative infection prevention company that operates in both Australian and international markets. The company specializes in the production and supply of advanced disinfection technologies, particularly for ultrasound probes, enhancing safety in medical environments.

Products and Services
  • trophon2: A high-level disinfection device for ultrasound probes
  • trophon EPR: A low-temperature disinfection solution for intra-cavity ultrasound transducers
  • Nanosonics AuditPro: A system for managing compliance with infection control workflows
Growth Outlook
  • Revenue growth of 102.4 million AUD in the latest quarter
  • Strong gross profit margin of 76.4% indicates operational efficiency
  • Continued investment in R&D to drive future product innovations
Financial Highlights
  • Net income of 9.6 million AUD for the latest quarter
  • Current ratio of 6.38 suggests strong liquidity position
  • Operating cash flow of 6.6 million AUD reflects solid cash generation
Nanosonics Limited has established itself as a leader in infection prevention technologies, particularly in the healthcare sector. The company's flagship products, such as the trophon2 and trophon EPR, are designed to meet the growing demand for effective disinfection solutions in medical settings. The recent quarterly revenue of 102.4 million AUD demonstrates robust market demand and operational success. The financial metrics indicate a strong liquidity position, with a current ratio of 6.38, allowing for flexibility in operations and investments. The net income of 9.6 million AUD in the latest quarter reflects the company's ability to generate profit while maintaining a focus on innovation and growth. Furthermore, the operating cash flow of 6.6 million AUD highlights the company's effective cash management practices. With a commitment to research and development, Nanosonics is well-positioned to introduce new products that address evolving healthcare challenges. The combination of strong financial performance and a focus on innovation makes Nanosonics Limited an intriguing option for potential investors interested in the healthcare technology sector.
AI Generated • Jul 26, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

470

CEO

Michael Kavanagh, MBA

Website

www.nanosonics.com.au

Headquarters

Macquarie Park, NSW 2113, AU

NNCSF Financials

Key Financial Metrics (TTM)

Gross Margin

77.17%

Operating Margin

8.95%

Net Income Margin

9.91%

Return on Equity

9.57%

Return on Capital

4.10%

Return on Assets

7.36%

Earnings Yield

1.99%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$654.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

298.72M

Volume

500

Avg. Volume

151.952

Financials (TTM)

Gross Profit

A$301.44M

Operating Income

A$32.74M

EBITDA

A$55.08M

Operating Cash Flow

A$64.33M

Capital Expenditure

-A$12.37M

Free Cash Flow

A$51.96M

Cash & ST Invst.

A$159.76M

Total Debt

A$9.88M

Nanosonics Performance Analysis

Nanosonics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 86,837,013N/A
20232023-06-30AUD 112,688,09729.8%
20242024-06-30AUD 112,436,794-0.2%
20252025-06-30AUD 128,442,71114.2%
Nanosonics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3012.2%
Q22024-12-314.7%
Q42025-06-3012.1%
Q22025-12-31-2.4%
Nanosonics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD 0.01N/A
20232023-06-30AUD 0.04391.0%
20242024-06-30AUD 0.03-37.1%
20252025-06-30AUD 0.0457.5%
Nanosonics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3058.4%
Q22024-12-31-1.2%
Q42025-06-3011.7%
Q22025-12-31-11.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$102.43M

+28.6%

Gross Profit

A$78.21M

+21.3%

Gross Margin

76.36%

N/A

Market Cap

$654.19MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.39M

N/A

Employees

470

N/A

Net Income

A$9.64M

+56.3%

EBITDA

A$12.81M

+133.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$159.76M

+35.0%

Total Debt

A$9.88M

-7.3%

Accounts Receivable

A$43.85M

+40.0%

Inventory

A$22.91M

-20.2%

Long Term Debt

A$6.41M

-16.0%

Short Term Debt

A$3.47M

+14.8%

Return on Assets

7.36%

N/A

Return on Invested Capital

7.65%

N/A

Free Cash Flow

A$4.34M

-45.1%

Operating Cash Flow

A$6.59M

-27.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TDVXFTobii Dynavox AB (publ)
$7.90+0.00%
PHCIPanamera Holdings Corporation
$2.50+0.00%
TGLVYTop Glove Corporation Bhd.
$0.57-3.30%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Questions About NNCSF

What is the current price of Nanosonics?

Nanosonics is trading at $2.19 per share.

What is the 52-week range for Nanosonics?

Over the past 52 weeks, Nanosonics has traded between $2.01 and $3.06.

How much debt does Nanosonics have?

As of the most recent reporting period, Nanosonics reported total debt of A$5.04M.

How much cash does Nanosonics have on hand?

Nanosonics reported A$105.93M in cash and cash equivalents in its most recent financial results.

What is Nanosonics’s dividend yield?

Nanosonics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services